段小辉,？ 邓锒梅,？ 陈雄,？ 等. MHCI链相关分子A/B在胰腺癌组织中的表达及临床意义[J]. 现代生物医学进展,？ 2009,？ 9(16):？ 3038-3040,？ 3045,？ 封2.？ [2]Morales-Buenrostro L E,？ Rodriguez-Romo R, de-Leo C, et al. HLA and MICA antibodies:？ further evidence of their impact on graft loss two years after their detection[J]. Clin Transpl,？ 2006,？ 207-218.？ [3]Andresen L,？ Jensen H,？ Pedersen M T, et al. Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells[J]. J Immunol,？ 2007,？ 179(12): 8235-8242.？ [4]Kim J S,？ Park Y S,？ Kim J Y, et al. Inhibition of human pancreatic tumor growth by cytokine-induced killer cells in nude mouse xenograft model[J]. Immune Netw,？ 2012,？ 12(6): 247-252.？ [5]Thanendrarajan S,？ Kim Y,？ Schmidt-Wolf I. New adoptive immunotherapy strategies for solid tumours with CIK cells[J]. Expert Opin Biol Ther,？ 2012,？ 12(5):？ 565-572.？ [6]Qiu Y,？ Yun M M,？ Xu M B, et al. Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders:？ findings from a pilot study[J]. Int J Clin Oncol, 2013,？ 18(4): 657-665. [7]Niam M,？ Linn Y C,？ Fook-Chong S, et al. Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy[J]. Exp Hematol,？ 2011,？ 39(9): 897-903.？ [8]Bae D S, Hwang Y K, Lee J K．Importance of NKG2D-NKG2D ligands interaction for cytolyticactivity of natural killer cell[J]．CellImmunol[J], 2012, 276（1/2）: 122-127．？ [9]Lu X,？ Zhu A,？ Cai X, et al. Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells[J]. Cancer Biol Ther,？ 2012,？ 13(8): 623-629. [10]Skov S,？ Pedersen M T,？ Andresen L, et al. Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B[J]. Cancer Res,？ 2005,？ 65(23): 11136-11145.？ [11]Tan G,？ Zhang X,？ Feng H, et al. The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptide[J]. Clin Dev Immunol,？？ 2011:？ 649359.？ [12]Engelken F J,？ Bettschart V,？ Rahman M Q, et al. Prognostic factors in the palliation of pancreatic cancer[J]. Eur J Surg Oncol,？ 2003,？ 29(4): 368-373.？ [13]Bae J H,？ Kim S J,？ Kim M J, et al. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction[J]. Cancer Sci,？ 2012,？ 103(1): 7-16.？ [14]高炳华，王新生. CML的基因沉默与过继免疫治疗的研究进展[J]. 军事医学， 2013， 37（11）： 870-872.？ [15]Xu X,？ Rao G S,？ Groh V, et al. Major histocompatibility complex class Ⅰ-related chain A/B (MIC/B) expression in tumor tissue and serum of pancreatic cancer:？ role of uric acid accumulation in gemcitabine-induced MICA/B expression[J]. BMC Cancer,？ 2011,？ 23(11): 1-11.？ [16]Zhang C,？ Wang Y,？ Zhou Z, et al. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis[J]. Cancer Immunol Immunother,？ 2009,？ 58(8):？ 1275-1285.？ [17]PoggiA,？ Zocchi M R. Mechanisms of tumor escape:？ role of tumor microenvironment in inducing apoptosis of cytolytic effector cells[J]. Arch Immunol Ther Exp (Warsz),？ 2006,？ 54(5): 323-333.？ [18]Klein A P. Identifying people at a high risk of developing pancreatic cancer[J]. Nat Rev Cancer,？ 2013,？ 13(1): 66-74.？ [19]张振沛,？ 李德海,？ 顾谦群,？ 等. 选择性HDAC抑制剂的研究进展[J]. 中国药物化学杂志,？ 2013,？ 23(4): 321-330.
[2]
蒋业贵,李兆申,刘同华,等.一条全长胰腺癌相关新基因的初步研究[J].第三军医大学学报,2007,29(17):1709. JIANG Ye-gui,LI Zhao-shen,LIU Tong-hua,et al.Characterization of a novel full-length gene associated with human pancreatic cancer[J].J Third Mil Med Univ,2007,29(23):1709. [2]蒋业贵,李兆申,王宇明,等.应用cDNA芯片技术筛选胰腺癌相关基因[J].第三军医大学学报,2006,28(03):235. [3]蒋业贵,李兆申,王宇明,等.1个新的胰腺癌相关基因的筛选和初步鉴定[J].第三军医大学学报,2007,29(04):360. JIANG Ye-gui,LI Zhao-shen,WANG Yu-ming,et al.Screening and identification of a novel gene-related human pancreatic cancer[J].J Third Mil Med Univ,2007,29(23):360. [4]李作生,郑贸根,王国臣.小细胞肺癌合并胰腺病变的治疗体会[J].第三军医大学学报,2010,32(04):375. [5]王正松,龚春梅,陈艳丹,等.胰腺癌中K-ras基因突变检测及其临床意义的初步探讨[J].第三军医大学学报,2011,33(21):2300. [6]张维,赵建农.联合运用肝脏三维容积超快速多期动态增强技术及扩散加权成像在胰腺癌诊断中的价值[J].第三军医大学学报,2008,30(20):1918. ZHANG Wei,ZHAO Jian-nong.Diagnostic value of combined LAVA and DWI for pancreatic carcinoma[J].J Third Mil Med Univ,2008,30(23):1918.
